Repository logo
 
Publication

Safety assessment of poly(methylmethacrylate) nanomaterials for drug delivery: genotoxicity in mammalian cells

2015-09-13Conference object Restricted access
Simple item page
dc.contributor.authorBettencourt, Ana
dc.contributor.authorGraça, DIogo
dc.contributor.authorMatos, A.
dc.contributor.authorFerreira, I.
dc.contributor.authorAlmeida, A.
dc.contributor.authorGonçalves, L.
dc.contributor.authorSantos, Joana
dc.contributor.authorLouro, Henriqueta
dc.contributor.authorSilva, Maria João
dc.date.accessioned2015-10-08T11:39:01Z
dc.date.available2016-09-13T00:30:08Z
dc.date.issued2015-09-13
dc.description.abstractThe application of nanomaterials (NMs) as carriers for drug delivery is seen as a key factor in innovative medicine products. A major class of drug controlled release systems includes polymeric NMs, due to their unique physicochemical properties that can be manipulated using well-established techniques. Among these, polymethylmethacrylate (PMMA) is a biomedical polymer with increasing interest as a carrier system of many drugs, e.g. antibiotics, for in situ therapy. However, the same unique properties that render these NMs so valuable may underlie unforeseen toxicological adverse side effects that must be assessed prior to their application. A major concern is their long-term effects, particularly, their potential genotoxicity, given that may persist in the human body. The present work aimed at synthesizing PMMA particles for drug delivery and assessing their safety through in vitro genotoxicity testing. PMMA particles were prepared by double emulsion-solvent-evaporation methodology and the relevant properties concerning their nano-biological interactions namely, size distribution, zeta potential and hydrophobicity were measured. As part of their safety assessment the cytotoxicity (MTT test) and genotoxicity (comet and micronucleus assays) were characterized using murine L929 fibroblasts. The results showed an absence of cytotoxicity and genotoxicity. In fact, neither DNA damage nor oxidative DNA damage was detected by the comet and FPG-modified comet assay, respectively. Furthermore, no clastogenicity/aneugenicity was observed by the micronucleus assay up to 5 mg/mL (OECD-TG 487 guideline). Further studies, including in vivo mutagenicity testing, are desirable for assuring the safe use of this NM.pt_PT
dc.identifier.urihttp://hdl.handle.net/10400.18/3181
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.relationFundação para a Ciência e Tecnologia and FEDER Grants SFRH/BD/69260/2010, research project EXCL/CTMNAN/ 0166/2012, and strategic projects PEst-OE/SAU/UI4013/2011 and PEst-OE/SAU/UI0009/2011pt_PT
dc.relation.publisherversionhttp://www.sciencedirect.com/science/article/pii/S0378427415025588
dc.subjectGenotoxicidade Ambientalpt_PT
dc.subjectGenotoxicitypt_PT
dc.subjectPolymethylmethacrylatept_PT
dc.subjectComet and Micronucleus Assaypt_PT
dc.titleSafety assessment of poly(methylmethacrylate) nanomaterials for drug delivery: genotoxicity in mammalian cellspt_PT
dc.typeconference object
dcterms.bibliographicCitationToxicology Letters. 2015; 238 (2, Suppl.):S208. doi:10.1016/j.toxlet.2015.08.619
dspace.entity.typePublication
oaire.citation.conferencePlacePorto, Portugalpt_PT
oaire.citation.title51st Congress of the European Societies of Toxicology (Eurotox): Bridging Sciences for Safety, 13-16 September 2015pt_PT
rcaap.rightsembargoedAccesspt_PT
rcaap.typeconferenceObjectpt_PT

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
2015_EUROTOX_final.pdf
Size:
854.65 KB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

DGH - Posters/abstracts em congressos internacionais